SENOLYTICSREDEFINED
The PCC1™ Procyanidin Difference — a precision formulation featuring our proprietary procyanidins blend (C1, B2, Epicatechin) manufactured at 199 Lonvi Labs.
"Zombie" Cell
Accumulation
Senescent cells are damaged cells that refuse to die naturally. They stay in your body like the "living dead" — functioning improperly while releasing inflammatory proteins (SASP) that may affect surrounding tissue and contribute to the aging process.
Precision
Targeting
Our PCC1™ Procyanidin Complex contains compounds that selectively target senescent cells. The procyanidins blend supports the body's natural cellular renewal processes, helping to maintain tissue function and supporting a healthy inflammatory response.
SYSTEMIC IMPACT
Tissue Support
Observed increase in healthy cell proliferation in research models.
Inflammatory Response
Reduction in SASP inflammatory markers observed in studies.
Longevity Research
Median lifespan extension observed in preclinical models.
Physical Vitality
Supported grip strength and mobility in research studies.
Cellular Markers
Positive changes in epigenetic aging clock markers observed.
Well-Tolerated
No adverse effects on healthy proliferating cells in studies.
PCC1™ Precision
PCC1™ is our proprietary procyanidins blend enriched with exceptionally high Procyanidin C1 content — far beyond what's found in nature. Combined with B2 and Epicatechin, our blend is well-tolerated and offers better absorption than standard grape seed extracts through our PCC1™ Phytosomal Technology.
- Selective cellular support
- Healthy inflammatory response
- Cellular wellness support
THE SQUAD
Boris Djordjevic
Founder & CEO
Visionary entrepreneur with a background in biochemistry and business. Founded 199 Longevity to bridge cutting-edge research and accessible health solutions.
Dr. Qinghua Lyu
Chief Technology Officer
PhD from NUS in Chemistry and Pharmacology. Specializes in optimizing chemical synthesis processes for polyphenols and senolytics.
Dr. Olivia Lesslar, MD
Business Development
Functional medicine physician and key opinion leader. Ensures products deliver measurable health impacts through evidence-based formulations.
Zico Yip
Chief Operating Officer
General Manager of laboratories and manufacturing. Brings deep biotech experience with successful fundraising and exits.